Evidence map›Paper›PMID 40148295›Full record

ReviewCurrent pharmaceutical design2025

A Mini-Review on the Symptoms and Pathogenesis of Psoriasis and Recent Nanotechnological Developments in its Treatment Strategies.

Harshita Mathur, Sadiya Halima, Rekha Gujjar, Ghanshyam Das Gupta, Balak Das Kurmi

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical design, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Harshita MathurDepartment of Pharmaceutical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, Punjab, India.
Sadiya HalimaDepartment of Pharmaceutics, Indo Soviet Friendship College of Pharmacy, GT Road, Moga, 142001, Punjab, India.
Rekha GujjarDepartment of Pharmaceutics, Indo Soviet Friendship College of Pharmacy, GT Road, Moga, 142001, Punjab, India.
Ghanshyam Das GuptaDepartment of Pharmaceutical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, Punjab, India.ORCID 0000-0002-5377-1082
Balak Das KurmiDepartment of Pharmaceutical Sciences, I.K. Gujral Punjab Technical University, Kapurthala, Punjab, India.ORCID 0000-0001-8470-6622

Funding

ICMR New Delhi 5/3/62/2020-ITR
6 · The paper itself

Abstract

Psoriasis is a chronic disease that is common and incurable. In psoriasis, skin cells proliferate more quickly than normal cells, suggesting a possible immune system connection. The topical treatment of psoriasis is best when applied in combination with anti-inflammatory medications; however, the lack of an appropriate delivery method limits the drugs' ability to be delivered. Due to several problems, including adverse reactions and problems with penetration, the current oral and topical treatments for psoriasis fall short of meeting the need for an optimal drug delivery method. None of them, however, can completely treat the illness safely and effectively without jeopardizing patient adherence. ILC3 typically contains retinoic acid receptor-related orphan receptor gamma t (RORγt) in its nucleus. Its development occurs when stimulated by IL-23 and IL-7, leading to the production of IL-22 and IL-17. Both the innate and adaptive immune systems are implicated in the recent, substantial advancements in genetics and molecular biology that have improved our understanding of PsA pathogenesis. Evidence-based targeted therapy has been introduced as a result, mostly using drugs known as tumour necrosis factor inhibitors. Because of their high ethanol concentration, etheromethanes provide more effective and improved bioavailability compared to previous dosing formulations. The principles, preparation process, most recent developments, and applications of ethosomes, however, are not well described in a systematic study. Size, shape, drug content, zeta potential, and other characteristics are examples of ethosome characteristics. Esthosomes can be prepared using four distinct methods, including thin-film hydration, the cold method, the hot method, and the reverse-phase evaporation method. All the information presented in this article was gathered from diverse sources, such as PubMed, ScienceDirect, Google Scholar, and various online platforms, like WHO, Globacon, and others.

Indexed as

Dermatologic AgentsNanotechnologyPsoriasisAnimalsDrug Delivery SystemsHumansDermatologic AgentsinflammationNanocarrierNLCs.psoriasistransdermalvesicles

Identifiers

PMID40148295

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.